Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study for Evaluation of Efficacy and Safety of Etanercept Versus Intra-articular Steroid Injection in Acute Synovitis

NCT: NCT00522184 · Status: COMPLETED · Phase: Phase 3 · Sponsor: Centre Hospitalier Universitaire de Nice · Started: 2005-02 · Est. Completion: 2006-11

Official Summary

Intra-articular injection of etanercept in patient suffering from rheumatoid arthritis: a double-blind randomized study for evaluation of efficacy and safety of etanercept versus intra-articular steroid injection in acute synovitis (knee,wrist,ankle,elbow)

Study Design

Interventions

Primary Outcomes

Eligibility Criteria

Inclusion Criteria:

* must be able to understand the information about the study
* diagnosis of rheumatoid arthritis for 6 month at least
* suffering for 2 weeks at least
* with evaluation of pain over 4/10
* with stable DMARDs treatment for three month at least

Exclusion Criteria:

* infection or surgery on the target joint
* treated with infliximab,adalimumab or anakinra

Trial Locations

More Rheumatoid Arthritis Trials

View all Rheumatoid Arthritis clinical trials

AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.